A panel of 12 breast cancer cell lines (including 8 TNBC lines) was treated with JUQ‑565 (0.001–10 µM) for 72 h. Viability was assessed by CellTiter‑Glo. GI₅₀ values were calculated using nonlinear regression.
Adult Video (AV) Report – JUQ-565